{
  "guideline": {
    "id": "PA166105003",
    "name": "Annotation of CPIC Guideline for allopurinol and HLA-B",
    "source": "CPIC",
    "version": 42,
    "url": "https://www.pharmgkb.org/guidelineAnnotation/PA166105003",
    "relatedChemicals": [
      {
        "id": "PA448320",
        "name": "allopurinol",
        "symbol": null
      }
    ],
    "relatedGenes": [
      {
        "id": "PA35056",
        "name": "major histocompatibility complex, class I, B",
        "symbol": "HLA-B"
      }
    ],
    "recommendation": true
  },
  "recommendations": [
    {
      "id": "PA166296961",
      "name": "Recommendation PA166296961",
      "population": "general",
      "classification": {
        "term": "Strong",
        "termId": "guidelineStrength:981501930"
      },
      "relatedChemicals": [
        {
          "id": "PA448320",
          "name": "allopurinol",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452059563,
        "html": "<p>Allopurinol is contraindicated</p>\n"
      },
      "implications": [
        "HLA-B: Significantly increased risk of allopurinol-induced SCAR"
      ],
      "lookupKey": {
        "HLA-B": "*58:01 positive"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166296760",
      "name": "Recommendation PA166296760",
      "population": "general",
      "classification": {
        "term": "Strong",
        "termId": "guidelineStrength:981501930"
      },
      "relatedChemicals": [
        {
          "id": "PA448320",
          "name": "allopurinol",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452059562,
        "html": "<p>Use allopurinol per standard dosing guidelines</p>\n"
      },
      "implications": [
        "HLA-B: Low or reduced risk of allopurinol-induced SCAR"
      ],
      "lookupKey": {
        "HLA-B": "*58:01 negative"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    }
  ],
  "citations": [
    {
      "pmid": "26094938",
      "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update.",
      "authors": [
        "Saito Y",
        "Stamp L K",
        "Caudle K E",
        "Hershfield M S",
        "McDonagh E M",
        "Callaghan J T",
        "Tassaneeyakul W",
        "Mushiroda T",
        "Kamatani N",
        "Goldspiel B R",
        "Phillips E J",
        "Klein T E",
        "Lee M T M",
        "Clinical Pharmacogenetics Implementation Consortium"
      ],
      "journal": "Clinical pharmacology and therapeutics",
      "year": 2016,
      "_sameAs": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675696"
    },
    {
      "pmid": "23232549",
      "title": "Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosing.",
      "authors": [
        "Hershfield M S",
        "Callaghan J T",
        "Tassaneeyakul W",
        "Mushiroda T",
        "Thorn C F",
        "Klein T E",
        "Lee M T M"
      ],
      "journal": "Clinical pharmacology and therapeutics",
      "year": 2013,
      "_sameAs": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564416"
    }
  ],
  "version": "2024-02-29-20-19"
}